A Randomized Study Evaluating Dapagliflozin and Metformin, Alone and in Combination, in Overweight Women With a Recent History of Gestational Diabetes Mellitus: Effects on Anthropometric Measurements and Cardiometabolic Abnormalities
Phase of Trial: Phase III
Latest Information Update: 15 May 2017
At a glance
- Drugs Dapagliflozin/metformin (Primary) ; Dapagliflozin; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms DAPA-GDM
- 08 May 2017 Planned End Date changed from 1 Mar 2018 to 1 Mar 2019.
- 08 May 2017 Planned primary completion date changed from 1 Nov 2017 to 1 Oct 2018.
- 25 Sep 2015 According to a media release, Ebymect received positive CHMP opinions for the treatment of type 2 diabetes mellitus.